<DOC>
	<DOCNO>NCT02819323</DOCNO>
	<brief_summary>The objective study compare safety , tolerance efficacy BLI800 PEG base preparation prior colonoscopy adolescent patient .</brief_summary>
	<brief_title>A Safety Efficacy Study Bowel Cleansing Preparation ( BLI800 ) Pediatric Subjects Undergoing Colonoscopy</brief_title>
	<detailed_description />
	<criteria>1 . Male female age 12 16 ( inclusive ) 2 . Undergoing colonoscopy routinely accept indication , include ( limited ) : Subjected inflammatory bowel disease ( IBD ) IBD followup Lower gastrointestinal bleeding Suspected colitis ( allergic ) Abdominal pain Chronic diarrhea Cancer surveillance Anemia unknown etiology Abnormal endosonography manometry Evaluation barium enema result 3 . If female , childbearing potential , subject must use acceptable form birth control remain abstinent duration study . 4 . Negative pregnancy test screening , applicable 5 . In Investigator 's judgment , caregiver mentally competent provide inform consent child participate study . 1 . Subjects know suspected ileus , impaction , severe ulcerative colitis , acute peritonitis , gastrointestinal obstruction , gastric retention ( gastroparesis ) , bowel perforation , toxic colitis megacolon . 2 . Subjects previous significant gastrointestinal surgery . 3 . Subjects increase risk bowel perforation , include connective tissue disorder , toxic dilation bowel recent bowel surgery . 4 . Subjects uncontrolled preexist electrolyte abnormality , clinically significant electrolyte abnormality base Visit 1 laboratory result , hypernatremia , hyponatremia , hyperphosphatemia , hypokalemia , hypocalcemia , uncorrected dehydration , secondary use diuretic angiotensin convert enzyme ( ACE ) inhibitor . 5 . Subjects bleed disorder and/or impaired platelet function , neutropenia . 6 . Subjects prior history renal , liver cardiac insufficiency ( include congestive heart failure significant cardiac abnormality ) 7 . Subjects estimate glomerular filtration rate ( GFR ) normal range ( le 70 ml/min/1.73m2 ) 8 . Subjects require take oral medication within 3 hour dose completion dos . 9 . Subjects impaired consciousness predisposes pulmonary aspiration . 10 . Subjects tendency nausea and/or vomiting , know swallow disorder . 11 . Subjects intake substance likely affect gastrointestinal motility urinary flow rate . 12 . Subjects undergo colonoscopy foreign body removal and/or decompression . 13 . Subjects abnormal ECG result Visit 1 . 14 . Subjects pregnant lactating , intend become pregnant study . 15 . Subjects childbearing potential refuse pregnancy test . 16 . Subjects history hypersensitivity preparation component . 17 . Subjects , opinion Investigator , include study reason , include inability follow study procedure history major medical/psychiatric condition would compromise safety study . 18 . Subjects participate investigational surgical , drug , device study within past 30 day . 19 . Subjects withdraw consent completion Visit 1 procedure .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>